Durability of Long‐Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV)
Journal of Medical Virology · 2026-01 · 98 (1)
DOI: 10.1002/jmv.70779 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Medical Virology, online erschienen am 29.12.2025. Verfasst von Filippo Lagi und 27 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. Hauptthemen laut MEDLINE: Rilpivirine, HIV Infections, Anti-HIV Agents, Pyridones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
To evaluate the durability of long‐acting cabotegravir (CAB) plus rilpivirine (RPV), available in Italy since June 2022, for maintaining HIV‐1 virological suppression. This multicentric observational study included 191 virologically suppressed adults (HIV‐RNA < 50 copies/mL) from 11 centers in Tuscany, followed from first CAB + RPV injection until discontinuation, death, or last visit. Discontinuation was defined as regimen switch or two consecutive missed doses, virological failure (VF) as two consecutive HIV‐RNA > 50 copies/mL or a single > 1000 copies/mL. Kaplan–Meier survival analysis assessed discontinuation rates. Follow‐up was 209.5 person‐years with a median of 1 year (IQR 0.5–1.5). Median age was 51 years (IQR 43–58); 81.7% were male; median ART duration was 13.8 years (IQR 8.7–20.2). Eighteen participants (9.2%) discontinued due to adverse events (3.7%), VF (2.6%), personal choice (2.1%), medical decision (0.5%), or loss to follow‐up (0.5%). Overall discontinuation was 8.5/100 person‐years (95% CI: 5.4–13.6). VF incidence was 2.3/100 person‐years (95% CI 0.9–5.7). All VFs, occurred within 28 weeks, except one at Week 72 with resistance mutations. Discontinuation rates were slightly higher than clinical trials but consistent with real‐world data. The VF incidence was slightly higher than reported in prior reports, highlighting the need for real‐life clinical monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
- Department of Medical Biotechnologies, Infectious and Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Senese, University of Siena, Siena, Italy.
- Infectious Diseases Unit, Misericordia Hospital, Azienda USL Toscana Sud-Est, Grosseto, Italy.
- Infectious Diseases Unit, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, Florence, Italy.
- Infectious Diseases Unit, Santo Stefano Hospital, Azienda USL Toscana Centro, Prato, Italy.
ORCID-Profile: Filippo Lagi
Zitieren
APA
Lagi, F., Formica, G., Fabbiani, M., Rossetti, B., Piccica, M., Pampaloni, A., Menichini, B., Costarelli, S., Bianco, C., Sarteschi, G., De Gennaro, M., Francalanci, E., Turco, M., Gasparro, G., Fognani, M., Corsi, P., Pozzi, M., Sterrantino, G., Tumbarello, M., …, & Bartoloni, A. (2026). Durability of Long‐Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV). Journal of Medical Virology, 98(1). https://doi.org/10.1002/jmv.70779
Vancouver
Lagi F, Formica G, Fabbiani M, Rossetti B, Piccica M, Pampaloni A, et al. Durability of Long‐Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV). Journal of Medical Virology. 2026;98(1). doi:10.1002/jmv.70779
BibTeX
@article{Lagi2026,
author = {Lagi, Filippo and Formica, Giuseppe and Fabbiani, Massimiliano and Rossetti, Barbara and Piccica, Matteo and Pampaloni, Alessio and Menichini, Beatrice and Costarelli, Silvia and Bianco, Claudia and Sarteschi, Giovanni and De Gennaro, Michele and Francalanci, Emanuela and Turco, Martina and Gasparro, Giuseppe and Fognani, Marco and Corsi, Paola and Pozzi, Marco and Sterrantino, Gaetana and Tumbarello, Mario and Messeri, Daniela and Costa, Cecilia and Adriani, Beatrice Anna and Nencioni, Cesira and Tacconi, Danilo and Sani, Spartaco and Vincenti, Antonella and Pisano, Luigi and Bartoloni, Alessandro},
title = {Durability of Long‐Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV)},
journal = {Journal of Medical Virology},
year = {2026},
volume = {98},
number = {1},
doi = {10.1002/jmv.70779}
}
EUVIMED